explore -WSS

explore

author：comprehensive 2025-09-29 01:38:11 - browse：575

This is the inaugural edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello! Welcome to the premiere issue of Adam’s Biotech Scorecard. I’m excited to get started. Let’s do this! (By the way, the AF in the logo are my initials, not the “other” AF.)

The contrarian view of Viking Therapeutics

Closeup financial chart

The developer of a dual-acting GLP-1/GIP treatment for obesity is riding high on positive data and takeout speculation. The drug, called VK2735, has shown impressive weight loss with minimal gastrointestinal side effects in both subcutaneous and oral formulations, positioning it as a strong challenger to the obesity juggernauts from Eli Lilly and Novo Nordisk. With a stock price that has soared nearly 800% over the past year, Viking is now a $9 billion company and a prime acquisition target for a cash-rich pharma company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Paxlovid rebound happens. Why and to whom are still a mystery

focus

WSS

CDC says it’s too soon to assess risk posed by Covid subvariant

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

California store owner shot dead in dispute over displaying Pride flag: Police

CDC says it’s too soon to assess risk posed by Covid subvariant

Roche's accidental data boosts hopes for anti

Restaurant meals are packed with calories, and we still keep eating them

hotspot

explore

The contrarian view of Viking Therapeutics

leisure time

Sports medicine is finally prioritizing gender equality

St. Louis police protesters begin picking up checks in $4.9 million settlement

Bright Health sells Medicare Advantage business to Molina

Roche's accidental data boosts hopes for anti

Affirmative action in medical school literally saved lives

Doctors push to include dialysis machines in emergency stockpile

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Kellogg’s is going to war over Mexico’s nutrition label rules

Wildfire smoke exposes gaps in outdoor worker protections

Sage considers ways to reduce costs following FDA rejection

leisure time

Health officials lay out plans to cope with respiratory virus season

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Hospital at home shows how to bring innovation to health care

Tuberculosis patients need more than just free medication

How to make over

Election results set back Medicaid expansion plans

focus

focus

hotspot

knowledge